1. Home
  2. IOVA vs ECO Comparison

IOVA vs ECO Comparison

Compare IOVA & ECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • ECO
  • Stock Information
  • Founded
  • IOVA 2007
  • ECO 2018
  • Country
  • IOVA United States
  • ECO Greece
  • Employees
  • IOVA N/A
  • ECO N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • ECO
  • Sector
  • IOVA Health Care
  • ECO
  • Exchange
  • IOVA Nasdaq
  • ECO Nasdaq
  • Market Cap
  • IOVA 771.4M
  • ECO 699.6M
  • IPO Year
  • IOVA N/A
  • ECO N/A
  • Fundamental
  • Price
  • IOVA $1.88
  • ECO $23.92
  • Analyst Decision
  • IOVA Buy
  • ECO Strong Buy
  • Analyst Count
  • IOVA 10
  • ECO 1
  • Target Price
  • IOVA $12.22
  • ECO $40.00
  • AVG Volume (30 Days)
  • IOVA 10.5M
  • ECO 145.7K
  • Earning Date
  • IOVA 08-07-2025
  • ECO 08-08-2025
  • Dividend Yield
  • IOVA N/A
  • ECO 9.27%
  • EPS Growth
  • IOVA N/A
  • ECO N/A
  • EPS
  • IOVA N/A
  • ECO 2.48
  • Revenue
  • IOVA $212,679,000.00
  • ECO $362,254,143.00
  • Revenue This Year
  • IOVA $86.62
  • ECO N/A
  • Revenue Next Year
  • IOVA $69.95
  • ECO $3.94
  • P/E Ratio
  • IOVA N/A
  • ECO $9.64
  • Revenue Growth
  • IOVA 11070.12
  • ECO N/A
  • 52 Week Low
  • IOVA $1.64
  • ECO $17.91
  • 52 Week High
  • IOVA $12.51
  • ECO $35.64
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 47.47
  • ECO 56.72
  • Support Level
  • IOVA $1.68
  • ECO $22.73
  • Resistance Level
  • IOVA $2.02
  • ECO $24.32
  • Average True Range (ATR)
  • IOVA 0.11
  • ECO 0.57
  • MACD
  • IOVA 0.03
  • ECO 0.13
  • Stochastic Oscillator
  • IOVA 61.42
  • ECO 81.19

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.

Share on Social Networks: